日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials

最大限度提高治疗成功率：按顺序参与囊性纤维化核酸疗法试验

期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(25)00206-1
Mayer-Hamblett, Nicole; Kerper, Natanya R; Clancy, John P; Davies, Jane C; Taylor-Cousar, Jennifer L; Donaldson, Scott H; Bell, Scott C; Jain, Raksha; Simmonds, Nicholas J; Mall, Marcus A; Goss, Christopher H; Rayment, Jonathan H; Setiawan, Linda; Pilewski, Joseph M
发表日期：2025
文献求助 收藏

Glycemia and Insulin Secretion in Cystic Fibrosis 2 Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO

囊性纤维化患者接受 Elexacaftor/Tezacaftor/Ivacaftor 治疗 2 年后血糖和胰岛素分泌情况：PROMISE-ENDO 研究

期刊:Journal of Clinical Endocrinology & Metabolism
影响因子:5.1
doi:10.1210/clinem/dgae857
Chan, Christine L; Shirley Bezerra, Meghan; Stefanovski, Darko; Gallop, Robert J; Walega, Rachel; Donaldson, Scott H; Frederick, Carla A; Freedman, Steven D; Gelfond, Daniel; Hoffman, Lucas R; Narkewicz, Michael R; Rowe, Steven M; Sagel, Scott D; Schwarzenberg, Sarah Jane; Solomon, George M; Stalvey, Michael S; Kelly, Andrea
MIS
免疫/内分泌
发表日期：2025
文献求助 收藏

New era, new GOALs: cardiovascular screening and lipid management in cystic fibrosis

新时代，新目标：囊性纤维化患者的心血管筛查和血脂管理

期刊:Therapeutic Advances in Respiratory Disease
影响因子:3
doi:10.1177/17534666251317200
Despotes, Katherine A; Ceppe, Agathe S; Goralski, Jennifer L; Donaldson, Scott H
发表日期：2025
文献求助 收藏

Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target

囊性纤维化中性粒细胞丝氨酸蛋白酶：在疾病发病机制中的作用及其作为治疗靶点的理论依据

期刊:European Respiratory Review
影响因子:10.4
doi:10.1183/16000617.0001-2024
Mall, Marcus A; Davies, Jane C; Donaldson, Scott H; Jain, Raksha; Chalmers, James D; Shteinberg, Michal
细胞生物学
中性粒细胞
粒细胞
发表日期：2024
文献求助 收藏

Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis

依来卡夫托/替扎卡夫托/伊伐卡夫托对囊性纤维化患者黏液和黏液纤毛清除的影响

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2023.10.010
Donaldson, Scott H; Corcoran, Timothy E; Pilewski, Joseph M; Mogayzel, Peter; Laube, Beth L; Boitet, Evan R; Harris, Elex S; Ceppe, Agathe; Edwards, Lloyd J; Zeman, Kirby; Wu, Jihong; Esther, Charles R Jr; Nichols, David P; Bennett, William D; Rowe, Steven M
发表日期：2024
文献求助 收藏

The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

停用高渗盐水或重组人脱氧核糖核酸酶对接受依来卡托/替扎卡托/伊伐卡托治疗的囊性纤维化患者黏液纤毛清除功能的影响：SIMPLIFY-MCC 研究

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2024.02.003
Donaldson, Scott H; Corcoran, Timothy E; Pilewski, Joseph M; Laube, Beth L; Mogayzel, Peter; Ceppe, Agathe; Wu, Jihong; Zeman, Kirby; Rowe, Steven M; Nichols, David P; Gifford, Alex H; Bennett, William D; Mayer-Hamblett, Nicole
MPL
LIF
发表日期：2024
文献求助 收藏

Analysis of Depression and Anxiety Scores Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Adults With Cystic Fibrosis

对囊性纤维化成人患者开始服用Elexacaftor/Tezacaftor/Ivacaftor后抑郁和焦虑评分的分析

期刊:Clinical Respiratory Journal
影响因子:2.3
doi:10.1111/crj.70007
Pudukodu, Harish; Powell, Margret Z; Ceppe, Agathe; Donaldson, Scott H; Goralski, Jennifer L; Sowa, Nathaniel A
神经科学
发表日期：2024
文献求助 收藏

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

在接受调节剂治疗的囊性纤维化患者中，停用高渗盐水或重组人脱氧核糖核酸酶（dornase alfa）与继续使用高渗盐水或dornase alfa的疗效比较（SIMPLIFY）：两项平行、多中心、开放标签、随机、对照、非劣效性试验的结果

期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(22)00434-9
Mayer-Hamblett, Nicole; Ratjen, Felix; Russell, Renee; Donaldson, Scott H; Riekert, Kristin A; Sawicki, Gregory S; Odem-Davis, Katherine; Young, Julia K; Rosenbluth, Daniel; Taylor-Cousar, Jennifer L; Goss, Christopher H; Retsch-Bogart, George; Clancy, John Paul; Genatossio, Alan; O'Sullivan, Brian P; Berlinski, Ariel; Millard, Susan L; Omlor, Gregory; Wyatt, Colby A; Moffett, Kathryn; Nichols, David P; Gifford, Alex H
MPL
LIF
发表日期：2023
文献求助 收藏

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

推进囊性纤维化临床试验项目：基于全球试验网络视角的新路线图

期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(23)00297-7
Mayer-Hamblett, Nicole; Clancy, John Paul; Jain, Raksha; Donaldson, Scott H; Fajac, Isabelle; Goss, Christopher H; Polineni, Deepika; Ratjen, Felix; Quon, Bradley S; Zemanick, Edith T; Bell, Scott C; Davies, Jane C; Jain, Manu; Konstan, Michael W; Kerper, Natanya R; LaRosa, Tré; Mall, Marcus A; McKone, Edward; Pearson, Kelsie; Pilewski, Joseph M; Quittell, Lynne; Rayment, Jonathan H; Rowe, Steven M; Taylor-Cousar, Jennifer L; Retsch-Bogart, George; Downey, Damian G
发表日期：2023
文献求助 收藏

Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI

Elexacaftor/tezacaftor/ivacaftor 与囊性纤维化患者的胃肠道结局：Promise-GI 报告

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2022.10.003
Schwarzenberg, Sarah Jane; Vu, Phuong T; Skalland, Michelle; Hoffman, Lucas R; Pope, Christopher; Gelfond, Daniel; Narkewicz, Michael R; Nichols, David P; Heltshe, Sonya L; Donaldson, Scott H; Frederick, Carla A; Kelly, Andrea; Pittman, Jessica E; Ratjen, Felix; Rosenfeld, Margaret; Sagel, Scott D; Solomon, George M; Stalvey, Michael S; Clancy, John P; Rowe, Steven M; Freedman, Steven D
发表日期：2023
文献求助 收藏